Skip to main content
TipRanks
Go Ultimate75% OFF

James Tessmer Insider Profile

4 Followers

James Tessmer, VP, Finance & Accounting at Lexicon Pharmaceuticals, holds 71.77K shares in Lexicon Pharmaceuticals (Ticker: LXRX).

James Tessmer's Trading History

LXRX
Lexicon Pharmaceuticals
Mar 16, 2021VP, Finance & AccountingUninformative Buy39.72K$128.46K
LXRX
Insider Shares: 71.77K (0.05%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 16, 2021Informative Sell$158.33K22,912$6.91+68.10%
Mar 16, 2021Uninformative Buy$39.72K12,000$3.31―
Mar 02, 2021Uninformative Buy$126.19K17,551$7.19―
Apr 24, 2020Uninformative Sell$7.83K3,997$1.96―
Apr 24, 2020Uninformative Buy$0.0013,262$0.00―

You May Also Like

James Tessmer insider profile FAQ

What is the percentage of profitable transactions made by James Tessmer?
The percentage of profitable transactions made by James Tessmer is 100%.
What is the average return per transaction made by James Tessmer?
The average return per transaction made by James Tessmer is 61.50%.
What stocks does James Tessmer hold?
James Tessmer holds: LXRX stocks.
What was James Tessmer’s latest transaction?
James Tessmer’s latest transaction was an Uninformative Buy of $39.72K.
What was James Tessmer's most profitable transaction?
James Tessmer’s most profitable transaction was an Informative Sell of LXRX stock on March 16, 2021. The return on the trade was 68.10%.
What is James Tessmer's role in Lexicon Pharmaceuticals?
James Tessmer's role in Lexicon Pharmaceuticals is VP, Finance & Accounting.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.